Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for SGA-induced metabolic effects
NCT01811160Phase 4Completed
- Sponsor
- Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
- Start
- Oct 2008
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in antipsychotic-induced weight gain (AIWG), metabolic syndrome, sponsored by Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Started Oct 2008; status: completed.
02
Drugs
melatonin
03
Conditions
antipsychotic-induced weight gain (AIWG)metabolic syndrome
Beyond the preview
Go deeper on NCT01811160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811160.